Suppr超能文献

类癌肿瘤肝转移的治疗。

Treatment of liver metastases of carcinoid tumors.

作者信息

Ahlman H, Westberg G, Wängberg B, Nilsson O, Tylén U, Scherstén T, Tisell L E

机构信息

Department of Surgery, Sahlgren University Hospital, Göteborg University, S-413 45 Göteborg, Sweden.

出版信息

World J Surg. 1996 Feb;20(2):196-202. doi: 10.1007/s002689900030.

Abstract

Liver metastases imply a major problem in patients with carcinoid tumors. Patients with localized disease should always undergo resection for cure. Patients with distant metastatic disease can also undergo resection for potential cure or symptom palliation because of the slow growth rate of many carcinoid tumors. In patients with the midgut carcinoid syndrome and bilobar hepatic disease we have performed primary surgery to relieve such symptoms as intestinal obstruction and ischemia, followed by successive embolizations of the hepatic arteries to reduce functional tumor burden in the liver. For optimal palliation, all patients with residual tumor were treated by octreotide. In a consecutive series of 64 patients with the midgut carcinoid syndrome we thus attained a 5-year survival rate of 70%. Fourteen of the patients underwent intentionally curative surgery (e.g., primary surgery followed by liver surgery). Of these patients, none died from their tumor disease during the period of study. The value of adjunctive interferon therapy is currently under evaluation.

摘要

肝转移在类癌患者中意味着一个重大问题。局限性疾病患者应始终接受根治性切除。由于许多类癌生长缓慢,远处转移性疾病患者也可接受切除以实现潜在治愈或缓解症状。对于患有中肠类癌综合征和双侧肝病的患者,我们进行了一期手术以缓解肠梗阻和缺血等症状,随后对肝动脉进行连续栓塞以减轻肝脏中的功能性肿瘤负担。为了实现最佳缓解,所有残留肿瘤患者均接受奥曲肽治疗。在连续的64例中肠类癌综合征患者中,我们因此获得了70%的5年生存率。其中14例患者接受了意向性根治性手术(如一期手术加肝脏手术)。在研究期间,这些患者中没有一人死于肿瘤疾病。辅助性干扰素治疗的价值目前正在评估中。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验